Discovery Life Sciences has acquired what claims to be the Maryland-based host of the world’s largest hepatocyte inventory, known as IVAL, to help researchers select more effective and safer drug…
The safety problems that continue to plague the JAK class as new data highlight some severe side effects are casting a large shadow over AbbVie’s Rinvoq. As a result of a recent readout highlighting…
Joseph Arron is sometimes referred to as the black sheep of his family. While everyone else is a professional musician, he was always more interested in science. ‘I played music, but I was never that…
In the early days of the pandemic, people cheered for nurses – delivering food, writing thank you notes and ringing bells nightly to show their appreciation. But something shifted this summer, and now…
China’s National Reimbursement Drug List (NRDL) is a crystal clear example of the country’s bargaining power in the biotech and pharma market, as more firms have reportedly agreed to cut their prices…
Two and a half years after driving his antisense oligonucleotide platform to Wall Street, Stoke Therapeutics CEO Ed Kaye is painting a fuller picture of the company’s first clinical data. And though…
Despite Ugur Sahin’s calls for calm over the Omicron variant — making a much more measured appeal than Moderna CEO Stéphane Bancel — the BioNTech chief is already predicting the potential need for new…
Acting FDA commissioner Janet Woodcock has been the face of just about every drug approval decision at the agency since the turn of the century. Since the pandemic began, she’s moved between the top…
Outside of Covid-19, 2021 has been the year of the accelerated approval. Beginning last spring, FDA openly challenged six
Clinical research services provider IQVIA will connect nurses and phlebotomists with clinical trial patients in their own homes. IQVIA says the mobile research teams will enhance patient experience,…
